Market Overview

Syntel Stock Performance May Come Under Pressure From Overzealous FY Rev Guidance & Estimates In Lieu Of Healthcare M&A

Share:
Related SYNT
Benzinga's Top Upgrades, Downgrades For April 20, 2018
The Market In 5 Minutes: Oil, Amazon, GW Pharma And More

JP Morgan Downgrades Syntel To Underweight From Neutral

Latest Ratings for SYNT

DateFirmActionFromTo
Apr 2018Wells FargoUpgradesUnderperformMarket Perform
Dec 2017Wells FargoDowngradesMarket PerformUnderperform
Dec 2017NeedhamDowngradesBuyHold

View More Analyst Ratings for SYNT
View the Latest Analyst Ratings

Posted-In: Analyst Color News Analyst Ratings

 

Related Articles (SYNT)

View Comments and Join the Discussion!